why choose us

First received: June 29, 2024

Clinical Trial: Time-Restricted Eating in Huntington's Disease: A Clinical Pilot Study

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Huntington Disease

Study Type: INTERVENTIONAL


Official Title: Safety, Feasibility, and Biomarker Effects of Time-restricted Eating for 12 Weeks in Early-stage Huntington's Disease.

Brief Summary: This trial examines whether 12 weeks of time-restricted eating (TRE), otherwise known as intermittent fasting, appears safe and feasible in persons with early-stage Huntington's disease (HD).The study also explores the effects of TRE on biomarkers and clinical measures associated with HD progression.

Read more